• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

缩窄性高血压大鼠对佛波酯的血管反应性

Vascular responsiveness to phorbol esters in coarctation-hypertensive rats.

作者信息

Turla M B, Park S M, Webb R C

机构信息

Department of Physiology, University of Michigan Medical School, Ann Arbor 48109-0622.

出版信息

J Hypertens. 1990 Feb;8(2):191-6. doi: 10.1097/00004872-199002000-00015.

DOI:10.1097/00004872-199002000-00015
PMID:2162884
Abstract

Recent observations suggest that a phospholipid-sensitive, calcium-dependent protein kinase affects the contractile responses of vascular smooth muscle. Protein kinase C activators such as the tumor-promoting phorbol esters have been used as tools to study protein kinase C function in various intact cells. The present study characterizes vascular reactivity to protein kinase C activation in rats made hypertensive by coarctation of the abdominal aorta. Thoracic aortic strips from hypertensive rats developed greater force than arteries from normotensive rats in response to the phorbol ester, 12-O-tetradecanoylphorbol-13-acetate (TPA). Thoracic aortae from hypertensive rats were more responsive (lower threshold dose) to the phorbol ester than those from normotensive rats. Additionally, arteries from hypertensive rats were more responsive to the contractile effects of mezerein, a non-phorbol ester activator of protein kinase C. Removal of the endothelium did not eliminate the difference in responsiveness to TPA in thoracic aortae from normotensive and hypertensive rats. The threshold dose of TPA in abdominal aortae from hypertensive rats was not different from that in normotensive rats. However, the maximal response to 10(-6) mol/l TPA after 60 min in abdominal aortae from hypertensive rats was significantly less than that in aortae from normotensive rats. Thus, contractile responses to TPA appear to be influenced by arterial pressure per se. The inhibitory effects of the calcium antagonist, verapamil, in thoracic aortae from hypertensive rats were greater than in those from normotensive rats. Verapamil inhibited TPA-induced contractions in abdominal aortae from hypertensive rats to the same extent as in those from normotensive rats.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

近期观察结果表明,一种对磷脂敏感、依赖钙的蛋白激酶会影响血管平滑肌的收缩反应。蛋白激酶C激活剂,如具有促肿瘤作用的佛波酯,已被用作研究蛋白激酶C在各种完整细胞中功能的工具。本研究描述了腹主动脉缩窄致高血压大鼠中血管对蛋白激酶C激活的反应性。与正常血压大鼠的动脉相比,高血压大鼠的胸主动脉条对佛波酯12 - O - 十四烷酰佛波醇 - 13 - 乙酸酯(TPA)产生的力量更大。高血压大鼠的胸主动脉对佛波酯的反应性更强(阈值剂量更低)。此外,高血压大鼠的动脉对蛋白激酶C的非佛波酯激活剂蜂毒素的收缩作用反应更敏感。去除内皮并不能消除正常血压和高血压大鼠胸主动脉对TPA反应性的差异。高血压大鼠腹主动脉中TPA的阈值剂量与正常血压大鼠的无差异。然而,高血压大鼠腹主动脉在60分钟后对10(-6) mol/l TPA的最大反应明显小于正常血压大鼠的主动脉。因此,对TPA的收缩反应似乎受动脉压本身影响。钙拮抗剂维拉帕米对高血压大鼠胸主动脉的抑制作用大于对正常血压大鼠胸主动脉的抑制作用。维拉帕米对高血压大鼠腹主动脉TPA诱导的收缩的抑制程度与对正常血压大鼠腹主动脉的相同。(摘要截于250字)

相似文献

1
Vascular responsiveness to phorbol esters in coarctation-hypertensive rats.缩窄性高血压大鼠对佛波酯的血管反应性
J Hypertens. 1990 Feb;8(2):191-6. doi: 10.1097/00004872-199002000-00015.
2
Vascular responsiveness to protein kinase C activators in mineralocorticoid-hypertensive rats.盐皮质激素性高血压大鼠血管对蛋白激酶C激活剂的反应性
J Hypertens. 1991 Mar;9(3):209-15. doi: 10.1097/00004872-199103000-00003.
3
Calcium and contractile responses to phorbol esters and the calcium channel agonist, Bay K 8644, in arteries from hypertensive rats.高血压大鼠动脉中钙及对佛波酯和钙通道激动剂Bay K 8644的收缩反应。
Am J Hypertens. 1990 Aug;3(8 Pt 2):245S-248S. doi: 10.1093/ajh/3.8.245.
4
Enhanced vascular reactivity to protein kinase C activators in genetically hypertensive rats.
Hypertension. 1987 Jun;9(6 Pt 2):III150-4. doi: 10.1161/01.hyp.9.6_pt_2.iii150.
5
Contractile responses to Bay K 8644 in rats with coarctation-induced hypertension.缩窄性高血压大鼠对Bay K 8644的收缩反应。
Proc Soc Exp Biol Med. 1993 May;203(1):92-9. doi: 10.3181/00379727-203-43578.
6
Functional study of the [Ca2+]i signaling pathway in aortas of L-NAME-hypertensive rats.L-NAME诱导高血压大鼠主动脉中[Ca2+]i信号通路的功能研究
Pharmacology. 2004 Mar;70(3):160-8. doi: 10.1159/000074979.
7
Endothelin-1-induced contraction in isolated aortae from normotensive and DOCA-salt hypertensive rats: effect of magnesium.内皮素-1诱导的正常血压和去氧皮质酮盐高血压大鼠离体主动脉收缩:镁的作用
Br J Pharmacol. 1996 Dec;119(7):1367-74. doi: 10.1111/j.1476-5381.1996.tb16048.x.
8
Effects of H-7 (protein kinase inhibitor) and phorbol ester on aortic strips from spontaneously hypertensive rats.H-7(蛋白激酶抑制剂)和佛波酯对自发性高血压大鼠主动脉条的作用。
Eur J Pharmacol. 1990 Jan 17;175(3):261-71. doi: 10.1016/0014-2999(90)90563-l.
9
Vascular smooth muscle responses to endothelial autacoids in rats with chronic coarctation hypertension.慢性缩窄性高血压大鼠血管平滑肌对内皮自分泌因子的反应
J Hypertens. 1993 Jan;11(1):65-74. doi: 10.1097/00004872-199301000-00010.
10
Contrasting effects of phorbol esters on serotonin- and vasopressin-evoked contractions in rat aorta and small mesenteric artery.佛波酯对大鼠主动脉和小肠系膜动脉中5-羟色胺和血管加压素诱发收缩的不同作用
Circ Res. 1992 May;70(5):978-90. doi: 10.1161/01.res.70.5.978.

引用本文的文献

1
Protein kinase Cα deletion causes hypotension and decreased vascular contractility.蛋白激酶 Cα 缺失导致低血压和血管收缩性降低。
J Hypertens. 2018 Mar;36(3):510-519. doi: 10.1097/HJH.0000000000001596.
2
Guanylyl cyclase/natriuretic peptide receptor-A signaling antagonizes phosphoinositide hydrolysis, Ca(2+) release, and activation of protein kinase C.鸟苷酸环化酶/利钠肽受体-A 信号通路拮抗磷酸肌醇水解、钙离子释放和蛋白激酶 C 的激活。
Front Mol Neurosci. 2014 Aug 22;7:75. doi: 10.3389/fnmol.2014.00075. eCollection 2014.
3
Chronic high pressure-induced arterial oxidative stress: involvement of protein kinase C-dependent NAD(P)H oxidase and local renin-angiotensin system.
慢性高压诱导的动脉氧化应激:蛋白激酶C依赖性NAD(P)H氧化酶和局部肾素-血管紧张素系统的参与
Am J Pathol. 2004 Jul;165(1):219-26. doi: 10.1016/S0002-9440(10)63290-7.
4
RhoA/Rho-kinase, vascular changes, and hypertension.RhoA/ Rho激酶、血管变化与高血压
Curr Hypertens Rep. 2001 Apr;3(2):139-44. doi: 10.1007/s11906-001-0028-4.
5
Therapeutic potential of protein kinase C inhibitors.蛋白激酶C抑制剂的治疗潜力。
Agents Actions. 1993 Jan;38(1-2):135-47. doi: 10.1007/BF02027225.